0
0
Recent reports have raised alarms about a potential association between popular weight loss medications, Ozempic (semaglutide) and Mounjaro (tirzepatide), and sudden vision loss. Several individuals have reported experiencing irreversible blindness after using these drugs, prompting investigations by health authorities.
Patient Experiences Highlight Potential Risks
James Norris, a 56-year-old mechanic from New Jersey, began using Mounjaro in March 2023 to address his weight concerns. While he achieved significant weight loss, Norris suffered sudden vision loss, leading to a diagnosis of non-arteritic anterior ischemic optic neuropathy (NAION). He is now pursuing legal action against the manufacturers, alleging insufficient warnings about potential severe side effects.
Similarly, Cheryl Bovee, a 60-year-old from Pennsylvania, experienced rapid vision loss after starting Ozempic. Despite initial improvements in her weight, the unexpected blindness has profoundly impacted her life. citeturn0news12
Studies Suggest Possible Link Between Medications and Vision Issues
A study published in JAMA Ophthalmology examined nine patients aged between 37 and 77 who developed vision problems after using semaglutide or tirzepatide. Conditions such as NAION and papillitis were observed, which involve reduced blood flow to eye structures. However, researchers caution that these findings do not confirm a direct causal relationship, and further studies are needed.
Health Authorities Initiate Investigations
European health officials are currently reviewing the potential link between Ozempic and NAION. The European Medicines Agency (EMA) announced the investigation following studies indicating that Ozempic may more than double the risk of developing this eye condition. Novo Nordisk, the manufacturer of Ozempic, maintains that the benefits of the medication outweigh the risks but acknowledges the importance of ongoing research. citeturn0news15
Expert Opinions and Recommendations
While the absolute risk remains low, experts suggest that the rapid reduction in blood sugar levels caused by these medications might affect blood flow to the eyes, potentially leading to vision issues. Patients considering these treatments are advised to discuss potential risks with their healthcare providers, especially if they have a history of eye conditions.
Disclaimer: This article is based on reports from various sources and does not constitute medical advice. Individuals concerned about the side effects of medications should consult with qualified healthcare professionals for personalized guidance.(https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/shocking-stories-of-people-who-went-blind-after-taking-ozempic-and-mounjaro/articleshow/118819663.cms)
